Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND1 pseudogene 1 (MTND1P1) is a non-functional DNA sequence that resembles the functional mitochondrial gene MT-ND1, which encodes a subunit of Complex I (NADH:ubiquinone oxidoreductase) in the electron transport chain. MTND1P1 does not encode a protein and does not participate directly in mitochondrial electron transport or energy production. By strict molecular biology convention, pseudogenes like MTND1P1 do not serve as direct therapeutic targets, have no known pharmacological modulators, and are not directly implicated in disease processes or used as biomarkers[3][4]. When investigating mitochondrial dysfunction or related disease mechanisms, the focus is always on the functional MT-ND1 gene—not its pseudogenes[2][3][4]. - MT-ND1 (not the pseudogene) is a crucial mitochondrial gene encoding a core subunit of respiratory chain Complex I and is involved in mitochondrial diseases such as MELAS, Leigh syndrome, and Leber hereditary optic neuropathy[2][3][4][5]. - The pseudogene MTND1P1 has none of these molecular functions, is not druggable, and should not be conflated with the functional MT-ND1 gene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND1 pseudogene 1 (MTND1P1).